Juxtapid and Humalog drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Juxtapid (lomitapide mesylate) and Humalog (insulin lispro recombinant). Common drug interactions include diarrhoea among females and blood glucose decreased among males.
The phase IV clinical study analyzes what interactions people have when they take Juxtapid and Humalog. It is created by eHealthMe based on reports of 30 people who take the same drugs from the FDA, and is updated regularly.
What is Juxtapid?
Juxtapid has active ingredients of lomitapide mesylate. eHealthMe is studying from 4,279 Juxtapid users. Check the latest studies of Juxtapid.
What is Humalog?
Humalog has active ingredients of insulin lispro recombinant. It is often used in diabetes. eHealthMe is studying from 137,127 Humalog users. Check the latest studies of Humalog.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
30 people who take Juxtapid and Humalog together, and have interactions are studied.

What are the common drug interactions of Juxtapid and Humalog, by gender? *:
female:
- Diarrhoea
- Nausea (feeling of having an urge to vomit)
- Weight increased
- Abdominal distension
- Blood cholesterol increased
- Blood glucose increased
- Constipation
- Dyspepsia (indigestion)
- Flatulence (flatus expelled through the anus)
- Stress
male:
- Blood glucose decreased
- Diarrhoea
- Vomiting
- Abdominal pain upper
- Hypoglycaemia (deficiency of glucose in the bloodstream)
- Hypoglycaemic unconsciousness (unconsciousness due to low blood sugar)
- Malaise (a feeling of general discomfort or uneasiness)
- Bowel movement irregularity
- Defaecation urgency (a sudden compelling urge to defecate)
- Dehydration (dryness resulting from the removal of water)
What are the common drug interactions of Juxtapid and Humalog, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Blood glucose decreased
- Bowel movement irregularity
- Defaecation urgency (a sudden compelling urge to defecate)
- Dehydration (dryness resulting from the removal of water)
- Diarrhoea
- Vomiting
50-59:
- Abdominal distension
- Dyspepsia (indigestion)
- Flatulence (flatus expelled through the anus)
- Nausea (feeling of having an urge to vomit)
- Abasia (inability to walk)
- Anxiety disorder
- Blood glucose decreased
- Cardiac failure congestive
- Chest pain
- Depression
60+:
- Diarrhoea
- Blood cholesterol increased
- Back pain
- Dyspnoea (difficult or laboured respiration)
- Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
- Lip swelling
- Pain
- Pain in extremity
- Palpitations (feelings or sensations that your heart is pounding or racing)
- Pharyngitis (inflammation of the pharynx, causing a sore throat)
What are the existing conditions these people have? *
- Type 2 Diabetes: 4 people, 13.33%
- Osteoarthritis (a joint disease caused by cartilage loss in a joint): 4 people, 13.33%
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 4 people, 13.33%
- High Blood Pressure: 4 people, 13.33%
- Depression: 4 people, 13.33%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 10.00%
- Sinusitis (inflammation of sinus): 2 people, 6.67%
* Approximation only. Some reports may have incomplete information.
Do you take Juxtapid and Humalog?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Juxtapid and Humalog:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Juxtapid:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Humalog:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Juxtapid and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Humalog and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on lomitapide mesylate and insulin lispro recombinant (the active ingredients of Juxtapid and Humalog, respectively), and Juxtapid and Humalog (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Enalapril Maleate And Hydrochlorothiazide cause Hyperhidrosis? - 4 seconds ago
- Drug interactions of Mounjaro and Vyvanse - 6 seconds ago
- Could Zoladex cause Respiratory Acidosis? - 6 seconds ago
- Could Amlodipine Besylate cause Infrequent Bowel Movements? - 10 seconds ago
- Could Enablex cause Impaired Gastric Emptying? - 11 seconds ago
- Could Ranitidine cause Ankylosing Spondylitis? - 12 seconds ago
- Could Emsam cause Nervousness? - 16 seconds ago
- Septra Ds vs. Doxycycline, side effect and effectiveness comparison - 19 seconds ago
- Could Botox cause Vitreous Floaters? - 21 seconds ago
- Drug interactions of Remicade and Atacand - 26 seconds ago